1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2017


DelveInsight’s, “ Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD). DelveInsight’s Report also assesses the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope

- The report provides competitivepipeline landscape of Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2017
Illustrative

- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Overview
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Pipeline Therapeutics
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Therapeutics under Development by Companies
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Filed and Phase III Products
- Comparative Analysis
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Phase II Products
- Comparative Analysis
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Phase I and IND Filed Products
- Comparative Analysis
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Discontinued Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Dormant Products
- Companies Involved in Therapeutics Development for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)
- Appendix
- Methodology
- Contact Us
- Disclaimer


List of Tables

- Number of Products under Development for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD), 2017
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2017
- Comparative Analysis Phase II Products, 2017
- Comparative Analysis Phase I and IND Filed Products, 2017
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2017
- Drug Candidates Profiles
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Monotherapy Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Combination Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Route of Administration
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Stage and Route of Administration
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Molecule Type
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Stage and Molecule Type
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Therapeutics - Discontinued Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Therapeutics - Dormant Products
- Products under Development by Companies, 2017


List of Figures

- Number of Products under Development for Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD), 2017
- Filed and Phase III Products, 2017
- Phase II Products, 2017
- Phase I and IND Filed Products, 2017
- Discovery and Pre-Clinical Stage Products, 2017
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Monotherapy Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Combination Products
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Route of Administration
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Stage and Route of Administration
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Molecule Type
- Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth

  • $ 4995
  • Industry report
  • October 2016
  • by GBI Research

Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth Summary Cardiovascular disease (CVD) covers a range of difference ...

Global Left Atrial Appendage Closure Market 2017-2021

Global Left Atrial Appendage Closure Market 2017-2021

  • $ 3500
  • Industry report
  • January 2017
  • by Infiniti Research Limited

About Left Atrial Appendage Closure Atrial fibrillation is one of the most common types of arrhythmia and is characterized by fast and irregular heart rhythms. The atria of patients suffering from the ...

Global and Chinese CVD Diamond Thick Film Industry, 2016 Market Research Report

Global and Chinese CVD Diamond Thick Film Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese CVD Diamond Thick Film Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global CVD Diamond Thick Film industry with ...


Download Unlimited Documents from Trusted Public Sources

AIDS Statistics and Cardiovascular Disease Statistics in Kenya

  • January 2017
    197 pages
  • AIDS  

    Infectious Dise...  

    Cardiovascular ...  

  • Kenya  

    Africa  

View report >

Diabetes Statistics in Bangladesh and Germany

  • January 2017
  • Diabetes  

    Cardiovascular ...  

    Type 2 Diabetes  

  • Bangladesh  

    Germany  

View report >

Type 2 Diabetes Statistics in the US

  • January 2017
    13 pages
  • Type 2 Diabetes  

    Diabetes  

  • United States  

View report >

Related Market Segments :

Cardiovascular Disease

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.